Sharon Henderson

As chronic disease costs soar, a new program from Health Coach Institute promises to professionalize wellness coaching with structured, systems-based training.

Newcomer Freedom Premium Finance partners with Input 1, leveraging a proven platform and regulatory support to enter the booming commercial premium finance market.

Activist investor Oasis challenges Kao's ethics, citing forced labor links and a recent ESG downgrade, pushing for an independent supply chain probe.

Graybar announces major leadership changes, positioning veteran executives to spearhead expansion, optimize its supply chain, and reinforce its market dominance.

The strategic acquisition merges SePRO's digital intelligence with advanced chemical treatments, forging a new front line against invasive species and water contamination.

With a key data readout looming for its chronic cough drug, Nocion adds a renowned dealmaker to its board, fueling speculation of a potential acquisition.

Responding to soaring AI and manufacturing demand, Cumming Group unifies 600+ specialists to build the world's most advanced high-tech facilities.

The network security firm's recent accolades underscore a critical industry move from managing complexity to mastering policy control across hybrid environments.

Private equity firm Mountaingate Capital acquires UpSwell Marketing, signaling a major trend: investing in tech that proves marketing’s bottom-line value.

Canadian innovator Stealth Health enters the U.S. with a dual-model telemedicine platform for longevity, targeting both patients and healthcare providers.

A UK-Czech partnership trials the world's first quantum-resilient drones, aiming to secure military data against future cyberattacks on the battlefield.

CZ.NIC launches a silent, rack-mountable 10Gbps router, championing open-source security, user privacy, and European technological independence.

NXP's Rafael Sotomayor will detail the future of AI in the real world, from autonomous cars to robotics, at Taipei's premier global tech event.

Shelton Capital adds $100M in tactical ETFs and a key derivatives expert, signaling an aggressive push in the competitive active management space.

With improved financials and progress on therapies for cannabis use disorder and Down syndrome, the French biotech charts a confident course for the future.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

UBS sees dozens of its Southeast advisors on Barron's 2026 list, signaling a strategic victory in a key growth market. What does this mean for clients?

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

Kekst CNC appoints 20-year veteran Lyndsey Estin as Co-CEO, signaling a strategic focus on AI and cybersecurity in a major leadership shift.

Analyses reveal the EPA allows pesticides with high cancer risks on the market without warning labels, raising major public health and legal questions.